Verging on RealityPatrick D McGorry |
From inside the book
Results 1-3 of 44
Page 66
... neuroleptic treatment . Conclusions Early and effective treatment of schizophrenia has been associated with better long - term outcome . Low - dose neuroleptic therapy is an effective treatment strategy and the diminished risk of side ...
... neuroleptic treatment . Conclusions Early and effective treatment of schizophrenia has been associated with better long - term outcome . Low - dose neuroleptic therapy is an effective treatment strategy and the diminished risk of side ...
Page 68
... neuroleptic threshold ' hypothesis ( McEvoy , 1986 ) , that is , opti- mal neuroleptic dose is the point where cogwheel rigidity discernible from baseline is detected . At the end - point , 26 of the 36 people ( 72 % ) were treated with ...
... neuroleptic threshold ' hypothesis ( McEvoy , 1986 ) , that is , opti- mal neuroleptic dose is the point where cogwheel rigidity discernible from baseline is detected . At the end - point , 26 of the 36 people ( 72 % ) were treated with ...
Page 69
... neuroleptic threshold dose at study com- pletion was 3.4 mg daily , whereas the mean dose in those randomised to one of the three dose increments was 11.6 mg . Of those maintained on the neuroleptic thres- hold dose throughout , 72 ...
... neuroleptic threshold dose at study com- pletion was 3.4 mg daily , whereas the mean dose in those randomised to one of the three dose increments was 11.6 mg . Of those maintained on the neuroleptic thres- hold dose throughout , 72 ...
Common terms and phrases
admission adolescence American Journal American Psychiatric Association antipsychotic medications Archives Birchwood BPRS Brief Psychiatric Rating British Journal clozapine cognitive cognitive therapy coping strategies depression diagnosis dose drug DSM-III-R duration of untreated early detection early intervention early psychosis effective episode schizophrenia EPPIC factors Falloon first-episode psychosis first-episode schizophrenia follow-up functioning group programme hallucinations haloperidol high-risk hospital hospitalisation identified in-patient individuals initial Journal of Psychiatry markedly deviant behaviour McGlashan McGorry mean s.d. measures ment Mental Disorders Mental Health months negative symptoms neuroleptic onset outcome PANSS participants patients person phase phrenia positive symptoms premorbid prevention prodromal prolonged recovery Psychiatric Rating Scale Psychological psychosocial psychotic disorders psychotic episode psychotic illness psychotic symptoms risk risperidone sample schizo schizoaffective disorder Schizophrenia Bulletin schizophreniform disorder scores self-efficacy showing markedly deviant social support stress substance misuse symp syndrome therapy tion University of Melbourne untreated psychosis variables